Form preview

Get the free IRS Form 8820 Orphan Drug Credit

Get Form
We are not affiliated with any brand or entity on this form
Illustration
Fill out
Complete the form online in a simple drag-and-drop editor.
Illustration
eSign
Add your legally binding signature or send the form for signing.
Illustration
Share
Share the form via a link, letting anyone fill it out from any device.
Illustration
Export
Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
Form preview

What is Form 8820

The IRS Form 8820 is a tax document used by taxpayers to claim the orphan drug credit, which covers 50% of eligible clinical testing expenses for rare disease drugs.

pdfFiller scores top ratings on review platforms

Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Show more Show less
Fill fillable 8820 form: Try Risk Free
Rate free 8820 form
4.3
satisfied
51 votes

Who needs Form 8820?

Explore how professionals across industries use pdfFiller.
Picture
Form 8820 is needed by:
  • Taxpayers involved in orphan drug development
  • Small pharmaceutical companies conducting clinical trials
  • Investors funding rare disease research
  • Accounting professionals managing client tax filings
  • Tax advisors assisting with orphan drug credits
  • Non-profit organizations engaged in rare disease advocacy

Comprehensive Guide to Form 8820

What is IRS Form 8820 Orphan Drug Credit?

IRS Form 8820 is designed for taxpayers seeking to claim the orphan drug credit, which represents 50% of qualified clinical testing expenses for drugs designated for rare diseases or conditions. This form plays a crucial role in supporting pharmaceutical research and development aimed at addressing the needs of those affected by rare diseases.
The connection between IRS Form 8820 and the orphan drug credit underscores the government's commitment to incentivize research into rare conditions. By reducing the financial burden associated with clinical testing, this tax credit fosters innovation within the pharmaceutical industry.

Purpose and Benefits of IRS Form 8820 Orphan Drug Credit

The primary purpose of IRS Form 8820 is to assist taxpayers in offsetting clinical testing costs associated with orphan drugs. This credit not only alleviates financial strain but also empowers pharmaceutical companies focusing on treatments for rare diseases.
Utilizing this tax form can yield significant financial savings for eligible businesses. Tax benefits derived from the orphan drug credit can substantially impact a company's cash flow, paving the way for continued investment in research and development.

Eligibility Criteria for IRS Form 8820

Taxpayers looking to claim the orphan drug credit must meet specific eligibility criteria. Firstly, the drugs must be designated for treating qualified rare diseases, defined as conditions affecting fewer than 200,000 individuals in the U.S.
Eligibility may vary by entity type:
  • Individuals may qualify but are generally less common.
  • Corporations, especially biotech firms, often account for most claims.
Entities should be aware of any restrictions that apply to their particular situation to ensure compliance when applying.

How to Fill Out IRS Form 8820 Online (Step-by-Step)

To complete IRS Form 8820 accurately, follow these steps:
  • Access the form through a reliable online platform.
  • Enter the drug name for which the credit is being claimed.
  • Input the designation application number and the date of designation.
  • Ensure all fields are filled out completely and accurately.
Double-checking each entry can help prevent common mistakes and ensure a smooth submission process.

Common Errors and How to Avoid Them When Filing IRS Form 8820

When completing IRS Form 8820, taxpayers frequently encounter several common errors. These may include:
  • Incorrect or missing designation application numbers.
  • Entering the wrong drug names or dates.
To avoid these pitfalls, implement strategies such as reviewing the form for completeness and having a second pair of eyes check the submission before filing.

Submission Methods for IRS Form 8820 Orphan Drug Credit

There are two primary methods for submitting IRS Form 8820: e-filing and mailing. E-filing offers a quicker processing time, while mailing allows for physical documentation.
Each submission method requires specific steps:
  • E-filing: Ensure you have the necessary software and documentation.
  • Mailing: Print the completed form, attach any required documentation, and send it to the appropriate IRS address.
Be aware of submission deadlines and processing times which may affect your tax status.

What Happens After You Submit IRS Form 8820?

Once IRS Form 8820 is submitted, the IRS undertakes a review process. Taxpayers can monitor the status of their applications through the IRS website or by direct inquiry.
If issues arise, such as a rejection or the need for amendments, it is crucial to follow the IRS's provided guidelines for rectifying the submission.

Security and Compliance When Handling IRS Form 8820

When managing IRS Form 8820, it is vital to prioritize data protection. Sensitive tax information requires stringent security measures to prevent unauthorized access.
pdfFiller implements industry-standard security protocols, including 256-bit encryption and compliance with HIPAA and GDPR regulations, ensuring user data remains safe throughout the form-filling process.

Utilizing pdfFiller for IRS Form 8820 Orphan Drug Credit

pdfFiller offers a user-friendly platform that simplifies the completion of IRS Form 8820. Users can easily edit, eSign, and share documents without downloading software.
The cloud-based features of pdfFiller facilitate seamless access and collaboration, making the process of filling out tax forms convenient and efficient.

Sample of a Completed IRS Form 8820 Orphan Drug Credit

To assist users, a sample of a completed IRS Form 8820 is available for review. This visual reference highlights key sections of the form and illustrates how to accurately complete the necessary fields.
Understanding the layout and required information can significantly aid in the application process, ensuring all critical components are correctly addressed.
Last updated on May 1, 2015

How to fill out the Form 8820

  1. 1.
    To access IRS Form 8820 on pdfFiller, go to the pdfFiller website and use the search bar to find 'IRS Form 8820'.
  2. 2.
    Once you find the form, click on it to open it in the pdfFiller editor.
  3. 3.
    Before completing the form, gather necessary information such as the name of the orphan drug, its designation application number, and the date of designation.
  4. 4.
    Use the toolbar to navigate through fillable fields. Click on each field to enter relevant data, and utilize any available checkboxes as needed.
  5. 5.
    Make sure to carefully fill in all sections relating to qualified clinical testing expenses incurred during the tax year.
  6. 6.
    After completing all fields, review the information entered for accuracy, ensuring compliance with IRS guidelines.
  7. 7.
    Once you are satisfied with the form, use the saving options in pdfFiller to download a copy or submit it directly through the platform as needed.
Regular content decoration

FAQs

If you can't find what you're looking for, please contact us anytime!
Eligibility for the Orphan Drug Credit applies to taxpayers who incur clinical testing expenses for drugs designated for rare diseases or conditions. It generally benefits small pharmaceutical companies and individual taxpayers engaged in orphan drug research.
Qualifying clinical testing expenses include costs related to the development and testing of drugs specifically designated for a rare disease. It's essential to maintain thorough documentation of these expenses for IRS purposes.
IRS Form 8820 must typically be submitted when filing your annual tax return. Check the IRS website for specific tax deadlines, as these can vary each year.
After completing Form 8820 on pdfFiller, you can either download it to your device and mail it to the IRS or submit it directly online if pdfFiller offers e-filing options. Always check IRS submission guidelines to ensure compliance.
Common mistakes include providing incorrect drug designation numbers, failing to document all qualified expenses, and overlooking necessary signatures. Double-checking all entries before submission can help avoid these pitfalls.
Processing times can vary by the IRS but typically range from several weeks to a few months. Factors include the volume of claims received and any additional documentation requests from the IRS.
Generally, there are no specific fees for filing Form 8820 itself. However, consider any costs for professional tax preparation services if you choose to seek assistance in completing the form.
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.